levofloxacin has been researched along with Bronchitis in 24 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 7 (29.17) | 18.2507 |
2000's | 13 (54.17) | 29.6817 |
2010's | 4 (16.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Al-Zaiti, SS; Carey, MG; Kozik, TM; Pelter, MM | 1 |
Babarina, MB; Sokolova, VI; Sychev, DA; Zaikov, DA | 1 |
Ishigaki, S; Kato, A; Yasuda, H | 1 |
Bielsa, S; Porcel, JM; Pubill-Fondevila, N | 1 |
Zuck, P | 1 |
Fujimura, M; Mizuguchi, M; Mizuhashi, K; Nakatsumi, Y; Sasaki, S; Yasui, M | 1 |
Blasi, F | 1 |
Fogarty, C; Fulambarker, A; Sethi, S | 1 |
Brumpt, I; Veyssier, P; Zuck, P | 1 |
Blasi, F; Cazzola, M; Donnarumma, G; Marchetti, F; Matera, MG; Sanduzzi, A; Tufano, MA | 1 |
Martinez, FJ | 1 |
Ambrusz, ME; Fisher, AC; Grossman, RF; Kahn, JB; Khashab, MM | 1 |
Maurin, N | 1 |
Odagiri, S | 1 |
Chuck, SK; Jung, R; Martin, SJ; Messick, CR; Meyer, JM; Pendland, SL | 1 |
Dolmann, A; Fiss, E; Maesen, FP; Shah, PM; Vetter, N; Wesch, R | 1 |
Fukayama, M; Inamatsu, T; Kita, Y; Masuda, Y; Yasuda, H; Yoshida, A | 1 |
Ariza, H; Ascoli, M; Casellas, JM; Dolmann, A; Gilardoni, M; Goldberg, M; Ivanovic, S; Montero, JM; Orduna, M; Tome, G | 1 |
Davies, BI; Maesen, FP | 1 |
Shah, PM | 1 |
Scheen, AJ | 1 |
Li-McLeod, J; Perfetto, EM | 1 |
Budanov, SV; Smirnova, LB; Vasil'ev, AN | 1 |
5 review(s) available for levofloxacin and Bronchitis
Article | Year |
---|---|
Role of levofloxacin in the treatment of lower respiratory tract infections (LRTIs).
Topics: Administration, Oral; Anti-Infective Agents; Bronchitis; Chronic Disease; Community-Acquired Infections; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fluoroquinolones; Follow-Up Studies; Humans; Infusions, Intravenous; Levofloxacin; Male; Ofloxacin; Pneumonia, Bacterial; Randomized Controlled Trials as Topic; Respiratory Tract Infections; Treatment Outcome | 2004 |
Acute exacerbation of chronic bronchitis: expanding short-course therapy.
Topics: Acute Disease; Aged; Anti-Bacterial Agents; Azithromycin; Bronchitis; Clinical Trials as Topic; Confidence Intervals; Double-Blind Method; Drug Administration Schedule; Humans; Levofloxacin; Microspheres; Middle Aged; Ofloxacin; Severity of Illness Index; Treatment Outcome | 2005 |
Levofloxacin and sparfloxacin: new quinolone antibiotics.
Topics: Absorption; Anti-Infective Agents; Bronchitis; Drug Interactions; Drug Resistance, Microbial; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Levofloxacin; Ofloxacin; Pneumonia; Quinolones; Sinusitis; Skin Diseases; Urinary Tract Infections | 1998 |
The use of levofloxacin in the treatment of respiratory tract infection.
Topics: Anti-Infective Agents; Bronchitis; Chronic Disease; Community-Acquired Infections; Haemophilus Infections; Haemophilus influenzae; Humans; Levofloxacin; Ofloxacin; Pneumonia, Bacterial; Pneumonia, Pneumococcal; Respiratory Tract Infections; Streptococcus pneumoniae | 2000 |
[The first 'respiration' fluoroquinolone--levofloxacin (Tavanic) in therapy of bacterial infections. Pharmacodynamics principles in optimization of administration regimens].
Topics: Acute Disease; Animals; Anti-Infective Agents; Bronchitis; Chronic Disease; Community-Acquired Infections; Humans; Levofloxacin; Maxillary Sinusitis; Ofloxacin; Pneumonia, Bacterial; Respiratory Tract Infections; Urinary Tract Infections | 2001 |
6 trial(s) available for levofloxacin and Bronchitis
Article | Year |
---|---|
Addition of a 2-month low-dose course of levofloxacin to long-term erythromycin therapy in sinobronchial syndrome.
Topics: Aged; Anti-Bacterial Agents; Anti-Infective Agents; Bronchiolitis; Bronchitis; Drug Therapy, Combination; Erythromycin; Female; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Sinusitis; Syndrome; Treatment Outcome | 2002 |
A randomized, double-blind study comparing 5 days oral gemifloxacin with 7 days oral levofloxacin in patients with acute exacerbation of chronic bronchitis.
Topics: Administration, Oral; Adult; Aged; Anti-Infective Agents; Bronchitis; Chronic Disease; Double-Blind Method; Drug Administration Schedule; Female; Fluoroquinolones; Gemifloxacin; Humans; Levofloxacin; Male; Middle Aged; Naphthyridines; Ofloxacin; Treatment Outcome | 2004 |
Pharmacodynamics of levofloxacin in patients with acute exacerbation of chronic bronchitis.
Topics: Acute Disease; Aged; Anti-Bacterial Agents; Area Under Curve; Bronchitis; Disease Progression; Female; Forced Expiratory Volume; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Predictive Value of Tests; Smoking; Sputum | 2005 |
Levofloxacin 750 mg QD for five days versus amoxicillin/clavulanate 875 mg/125 mg BID for ten days for treatment of acute bacterial exacerbation of chronic bronchitis: a post hoc analysis of data from severely ill patients.
Topics: Aged; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacterial Infections; Bronchitis; Chronic Disease; Drug Administration Schedule; Female; Humans; Levofloxacin; Male; Ofloxacin | 2006 |
Levofloxacin versus cefuroxime axetil in the treatment of acute exacerbation of chronic bronchitis: results of a randomized, double-blind study.
Topics: Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Bronchitis; Cefuroxime; Cephalosporins; Chronic Disease; Double-Blind Method; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Levofloxacin; Middle Aged; Ofloxacin; Treatment Outcome | 1999 |
Clinical effectiveness of levofloxacin in patients with acute purulent exacerbations of chronic bronchitis: the relationship with in-vitro activity.
Topics: Aged; Anti-Infective Agents; Bronchitis; Cefuroxime; Cephalosporins; Chronic Disease; Double-Blind Method; Female; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Ofloxacin; Streptococcus pneumoniae; Treatment Outcome | 1999 |
13 other study(ies) available for levofloxacin and Bronchitis
Article | Year |
---|---|
Drug Induced ECG Abnormalities.
Topics: Anti-Bacterial Agents; Bronchitis; Electrocardiography; Female; Humans; Levofloxacin; Long QT Syndrome; Middle Aged | 2015 |
[Prospects of Levofloxacin Use in Therapy of Patients with Bronchopulmonary Diseases or Skin and Soft Tissue Pyo-Inflammatory Lesions].
Topics: Adult; Anti-Bacterial Agents; Bronchitis; Dose-Response Relationship, Drug; Female; Humans; Levofloxacin; Lung Diseases; Male; Microbial Sensitivity Tests; Middle Aged; Pneumonia, Bacterial; Severity of Illness Index; Skin Diseases, Bacterial; Soft Tissue Infections; Treatment Outcome; Tuberculosis, Pulmonary; Young Adult | 2014 |
Levofloxacin-associated Achilles tendinitis in a patient with chronic kidney disease stage 5.
Topics: Achilles Tendon; Bronchitis; Female; Humans; Kidney Failure, Chronic; Levofloxacin; Magnetic Resonance Imaging; Middle Aged; Ofloxacin; Tendinopathy | 2011 |
[Levofloxacin hepatotoxicity].
Topics: Adult; Alanine Transaminase; Anti-Bacterial Agents; Aspartate Aminotransferases; Bronchiectasis; Bronchitis; Ceftriaxone; Chemical and Drug Induced Liver Injury; Drug Substitution; gamma-Glutamyltransferase; Hepatomegaly; Humans; Hyperbilirubinemia; Levofloxacin; Male; Ofloxacin | 2013 |
[Update on the use of levofloxacin in the management of acute exacerbations of chronic bronchitis with risk factors].
Topics: Acute Disease; Adult; Age Factors; Aged; Aged, 80 and over; Anti-Infective Agents; Bronchitis; Chronic Disease; Drug Resistance; Female; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Patient Care Planning; Recurrence; Risk Factors | 2002 |
[Efficacy of levofloxacin in the treatment of acute exacerbation of chronic bronchitis in patients with risk factors].
Topics: Acute Disease; Anti-Bacterial Agents; Bronchitis; Chronic Disease; Clinical Trials as Topic; Humans; Levofloxacin; Ofloxacin; Risk Factors | 2004 |
[Fluoroquinolone-induced Achilles tendon rupture].
Topics: Achilles Tendon; Aged; Anti-Bacterial Agents; Bronchitis; Diabetes Mellitus, Type 1; Female; Humans; Levofloxacin; Ofloxacin; Pulmonary Disease, Chronic Obstructive; Risk Factors; Rupture; Tendinopathy; Tendon Injuries; Ultrasonography | 2008 |
Levofloxacin in patients with severe respiratory tract infection.
Topics: Aged; Anti-Bacterial Agents; Anti-Infective Agents; Asthma; Bronchitis; Chronic Disease; Clarithromycin; Drug Therapy, Combination; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Ofloxacin; Pseudomonas aeruginosa; Respiratory Tract Infections | 1995 |
Sparfloxacin and levofloxacin.
Topics: Administration, Oral; Anti-Infective Agents; Bronchitis; Chronic Disease; Clinical Trials as Topic; Drug Eruptions; Fluoroquinolones; Gastrointestinal Diseases; Humans; Levofloxacin; Ofloxacin; Photosensitivity Disorders; Pneumonia; Quinolones | 1997 |
[Levofloxacin-induced neurological adverse effects such as convulsion, involuntary movement (tremor, myoclonus and chorea like), visual hallucination in two elderly patients].
Topics: Aged; Aged, 80 and over; Anti-Infective Agents; Bronchitis; Dyskinesia, Drug-Induced; Hallucinations; Humans; Levofloxacin; Male; Ofloxacin; Respiratory Tract Infections; Seizures | 1999 |
Comparative in-vitro activity of levofloxacin against isolates of bacteria from adult patients with community-acquired lower respiratory tract infections.
Topics: Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Bacteria; Bronchitis; Chronic Disease; Community-Acquired Infections; Haemophilus influenzae; Humans; Levofloxacin; Microbial Sensitivity Tests; Middle Aged; Moraxella catarrhalis; Ofloxacin; Penicillin Resistance; Pneumonia, Bacterial; Pseudomonas aeruginosa; Streptococcus pneumoniae | 1999 |
[Pharma-clinics. The drug of the month. Levofloxacin (Tavanic)].
Topics: Acute Disease; Anti-Infective Agents; Anti-Infective Agents, Urinary; Bacterial Infections; Bronchitis; Community-Acquired Infections; Humans; Levofloxacin; Ofloxacin; Pneumonia, Bacterial; Sinusitis; Urinary Tract Infections | 2000 |
Workplace costs associated with acute exacerbation of chronic bronchitis: a comparison of moxifloxacin and levofloxacin.
Topics: Absenteeism; Adolescent; Adult; Anti-Infective Agents; Bronchitis; Chronic Disease; Cost of Illness; Cost-Benefit Analysis; Efficiency; Employer Health Costs; Female; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; United States | 2001 |